InspireMD Acquires Subsidiary for $1M
Ticker: NSPR · Form: 8-K · Filed: May 28, 2024 · CIK: 1433607
| Field | Detail |
|---|---|
| Company | Inspiremd, INC. (NSPR) |
| Form Type | 8-K |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, subsidiary, restructuring
TL;DR
InspireMD buying its own subsidiary for $1M to clean up the books.
AI Summary
InspireMD, Inc. announced on May 28, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of its subsidiary, InspireMD Ltd., for approximately $1.0 million in cash. This transaction aims to simplify the company's corporate structure and enhance operational efficiency.
Why It Matters
This acquisition simplifies InspireMD's corporate structure, potentially leading to more streamlined operations and clearer reporting for investors.
Risk Assessment
Risk Level: low — The acquisition of a subsidiary for a relatively small amount is unlikely to introduce significant new risks to the company.
Key Numbers
- $1.0M — Acquisition Price (Cash paid for the acquisition of InspireMD Ltd.)
Key Players & Entities
- InspireMD, Inc. (company) — Registrant
- InspireMD Ltd. (company) — Subsidiary being acquired
- $1.0 million (dollar_amount) — Acquisition price
- May 28, 2024 (date) — Announcement date
FAQ
What is the primary purpose of acquiring InspireMD Ltd.?
The primary purpose is to simplify the company's corporate structure and enhance operational efficiency.
What is the total cash consideration for the acquisition?
The total cash consideration is approximately $1.0 million.
When was the definitive agreement for the acquisition entered into?
The definitive agreement was entered into on May 28, 2024.
What is the relationship between InspireMD, Inc. and InspireMD Ltd. prior to the acquisition?
InspireMD Ltd. is a subsidiary of InspireMD, Inc.
What is the expected impact of this acquisition on InspireMD, Inc.'s operations?
The acquisition is expected to enhance operational efficiency by simplifying the corporate structure.
Filing Stats: 718 words · 3 min read · ~2 pages · Grade level 11 · Accepted 2024-05-28 09:05:36
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share NSPR The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 31KB
- ex99-2.htm (EX-99.2) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- ex99-2_001.jpg (GRAPHIC) — 230KB
- ex99-2_002.jpg (GRAPHIC) — 234KB
- ex99-2_003.jpg (GRAPHIC) — 274KB
- ex99-2_004.jpg (GRAPHIC) — 308KB
- ex99-2_005.jpg (GRAPHIC) — 459KB
- ex99-2_006.jpg (GRAPHIC) — 395KB
- ex99-2_007.jpg (GRAPHIC) — 363KB
- ex99-2_008.jpg (GRAPHIC) — 282KB
- ex99-2_009.jpg (GRAPHIC) — 260KB
- ex99-2_010.jpg (GRAPHIC) — 389KB
- ex99-2_011.jpg (GRAPHIC) — 336KB
- ex99-2_012.jpg (GRAPHIC) — 220KB
- ex99-2_013.jpg (GRAPHIC) — 198KB
- ex99-2_014.jpg (GRAPHIC) — 187KB
- ex99-2_015.jpg (GRAPHIC) — 447KB
- ex99-2_016.jpg (GRAPHIC) — 343KB
- ex99-2_017.jpg (GRAPHIC) — 246KB
- ex99-2_018.jpg (GRAPHIC) — 219KB
- ex99-2_019.jpg (GRAPHIC) — 262KB
- ex99-2_020.jpg (GRAPHIC) — 404KB
- ex99-2_021.jpg (GRAPHIC) — 225KB
- 0001493152-24-021463.txt ( ) — 8919KB
- nspr-20240528.xsd (EX-101.SCH) — 3KB
- nspr-20240528_lab.xml (EX-101.LAB) — 33KB
- nspr-20240528_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: May 28, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer